Gad Thomas

CIK 00017532241 companyPRINCETON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001753224

Recent Transactions

50 trades

Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−242,200→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−110,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−100,000→ 0 total
Disposition from Tender
Y-mAbs Therapeutics, Inc.
Common Stock
2025-09-16$8.60/sh−60,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−64,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Common Stock
2025-09-16−60,235→ 0 total
Disposition from Tender
Y-mAbs Therapeutics, Inc.
Common Stock
2025-09-16$8.60/sh−67,681→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−130,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−143,169→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−107,500→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−16,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−91,450→ 0 total
Disposition from Tender
Y-mAbs Therapeutics, Inc.
Common Stock
2025-09-16$8.60/sh−245,486→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−75,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−132,500→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Restricted Stock Units
2025-09-16−16,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−60,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Restricted Stock Units
2025-09-16−16,000→ 0 total
Exercise/Conversion
Y-mAbs Therapeutics, Inc.
Common Stock
2025-06-03$2.00/sh+103,000→ 305,721 total
Exercise/Conversion
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-06-03−103,000→ 0 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2025-03-07$5.23/sh−10,810→ 202,721 total
Award
Y-mAbs Therapeutics, Inc.
Common Stock
2025-01-17+32,000→ 213,531 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-01-17+64,000→ 64,000 total
Exercise/Conversion
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-09-19−22,831→ 143,169 total
Exercise/Conversion
Y-mAbs Therapeutics, Inc.
Common Stock
2024-09-19$4.38/sh+22,831→ 181,531 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2024-09-16$12.97/sh−30,000→ 67,681 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2024-09-13$13.47/sh−65,000→ 97,681 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2024-06-11$12.00/sh−35,000→ 162,681 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2024-06-10$12.03/sh−35,000→ 197,681 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2024-05-23$13.00/sh−7,351→ 232,681 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2024-05-21$12.00/sh−25,000→ 240,032 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2024-03-05$16.44/sh−3,900→ 158,700 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-01-18+132,500→ 132,500 total
Award
Y-mAbs Therapeutics, Inc.
Common Stock
2024-01-18+22,100→ 162,600 total
Exercise/Conversion
Y-mAbs Therapeutics, Inc.
Common Stock
2023-12-21$2.00/sh+50,000→ 140,500 total
Exercise/Conversion
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-12-21−50,000→ 103,000 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2023-12-15$6.61/sh−50,000→ 265,032 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2023-12-14$6.83/sh−50,000→ 315,032 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2023-12-13$6.58/sh−50,000→ 365,032 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2023-11-21$5.31/sh−75,000→ 415,032 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2023-11-20$5.30/sh−75,000→ 490,032 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-11-06+75,000→ 75,000 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-01-17+243,200→ 243,200 total
Award
Y-mAbs Therapeutics, Inc.
Common Stock
2023-01-17+40,500→ 90,500 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2022-05-18+60,000→ 60,000 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2022-02-09$6.96/sh−64,276→ 565,032 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2022-02-08$7.01/sh−125,863→ 629,308 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2022-02-07$7.59/sh−91,031→ 755,171 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2022-02-04$7.70/sh−101,104→ 846,202 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2022-02-03$7.90/sh−35,060→ 947,306 total

Companies

Y-mAbs Therapeutics, Inc.
Director, CHIEF BUSINESS OFFICER

Recent Filings

Address

C/O Y-MABS THERAPEUTICS, INC. 202 CARNEGIE CENTER, SUITE 301

PRINCETON, NJ, 08540

View on SEC.gov